Sequent Medical

Sequent Medical has developed innovative catheter-based technologies for the treatment of neurovascular diseases. The company has invented and developed proprietary Microbraid™ technology to create the WEB® Aneurysm Embolization System, a compelling and versatile new option for treating both ruptured and unruptured aneurysms. The WEB has received the CE mark and has been used to treat over 280 aneurysms in Europe and Latin America to date. The WEB is not sold or used in the United States. Sequent Medical, Inc. is headquartered in Aliso Viejo, California, with a European office in Bonn, Germany.